Investing in Biomedical Innovation for Health and Economic Growth
Senior Industry Leaders Shared Their Insights
This Financial Times webinar, hosted in partnership with ViiV Healthcare, brought together policymakers, funders, researchers, philanthropies and industry leaders to explore how to keep medical innovation moving forward. The conversation examined how to create the right conditions for future breakthroughs – and deliver clear benefits for patients, health systems, economies and society. Speakers discussed how to better recognise the economic, health and social impact of new medicines, how partnerships can help share risk and accelerate progress, and how new funding models could support the next generation of drug development.
The Investment Case
How can we better show the value of medical innovation to support investment and policy reform?
Strategic Partnerships
How can partnerships help share risk and accelerate progress in the development of new medicines and other health innovations?
Next Generation Breakthroughs
What can progress in chronic and infectious diseases teach us about how to support the next generation of biomedical innovations?
FT Live Digital Dialogues - fully digital 50-minutue event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.